Clinical Trials Directory

Trials / Terminated

TerminatedNCT02191917

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)

A Study of Respiratory Muscle Strength, Including Effort-Independent Measures, in Subjects With Late-Onset Pompe Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
BioMarin Pharmaceutical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study 701-201 is a study in patients with late-onset Pompe disease (LOPD). The study will test respiratory muscle strength initially and again after 24 weeks in subjects treated or not treated with BMN 701 .

Conditions

Interventions

TypeNameDescription
PROCEDURERespiratory muscle strength measurements by different techniques.

Timeline

Start date
2014-10-21
Primary completion
2016-06-22
Completion
2016-06-22
First posted
2014-07-16
Last updated
2023-01-09
Results posted
2023-01-09

Locations

2 sites across 2 countries: United States, United Kingdom

Source: ClinicalTrials.gov record NCT02191917. Inclusion in this directory is not an endorsement.